Malach M, Imperato P J, Nenner R P, Huang T, Dearie M B
New York University School of Medicine, New York, USA.
Am J Med Qual. 1998 Winter;13(4):213-22. doi: 10.1177/106286069801300407.
The value and necessity of performing right heart catheterizations for coronary artery disease have been increasingly questioned. Preliminary analyses of the procedure among Medicare and Medicaid patients in New York State revealed significant inter-hospital variations in the frequencies with which such catheterizations were performed. These data suggested that right heart catheterizations (RHC) were being performed routinely. Medicare and Medicaid claims data for bilateral catheterizations were analyzed before and after an educational intervention program involving the state's 53 catheterization laboratories. The educational intervention was multifaceted and consisted of disseminating suggested guidelines established with the assistance of the New York State Chapter of the American College of Cardiology, the Committee on Cardiovascular Disease of the Medical Society of the State of New York, and the Cardiac Advisory Council of the New York State Department of Health. Posteducational intervention assessments were made over a 4-year period. The baseline data for 1992 demonstrated that 10 (18.4%) laboratories had performed RHC routinely (70-100%) on Medicare and Medicaid patients undergoing catheterization. In contrast, 34 (64.2%) laboratories performed RHC in less than 20% of their Medicare cases, whereas 39 (73.5%) did so among Medicaid cases. Eighteen (34%) laboratories performed RHC in less than 10% of Medicare cases. These data indicated that there was significant inter-hospital variation in the frequency with which RHC was performed. Beginning in 1993, ongoing educational meetings and conferences were held with all laboratories, but especially with the 10 that were at the high end of the RHC performance level. As a result of this ongoing intervention, the rate of RHC among Medicare patients fell from 89/100,000 in 1992 to 65/100,000 beneficiaries in 1996. From another perspective, the percentage of catheterized Medicare patients undergoing RHC fell from 30.5% in 1992 to 17.4% in 1996. The decline among the 10 laboratories was even more dramatic; the percentage of catheterized Medicare patients undergoing RHC fell from 89.1% in 1992 to 31.6% in 1996. The parallel drop for Medicaid patients over the same time period was from 92.8 to 32.7%. The results of the study indicate that many previously performed RHC in patients with coronary artery disease were routine and not medically indicated. The dramatic decreases in RHC documented in this study over a 4-year period demonstrate the success of quality improvement efforts jointly undertaken by providers and a peer review organization.
对于冠状动脉疾病患者进行右心导管检查的价值和必要性受到了越来越多的质疑。对纽约州医疗保险和医疗补助患者进行的该检查的初步分析显示,各医院在进行此类导管检查的频率上存在显著差异。这些数据表明右心导管检查(RHC)在被常规进行。在一项涉及该州53个导管实验室的教育干预项目前后,对医疗保险和医疗补助双边导管检查的理赔数据进行了分析。该教育干预是多方面的,包括传播在美国心脏病学会纽约州分会、纽约州医学协会心血管疾病委员会以及纽约州卫生部心脏咨询委员会协助下制定的建议指南。在4年期间进行了教育干预后的评估。1992年的基线数据显示,10个(18.4%)实验室对接受导管检查的医疗保险和医疗补助患者常规进行RHC(70 - 100%)。相比之下,34个(64.2%)实验室在不到20%的医疗保险病例中进行RHC,而39个(73.5%)实验室在医疗补助病例中如此。18个(34%)实验室在不到10%的医疗保险病例中进行RHC。这些数据表明,各医院在进行RHC的频率上存在显著差异。从1993年开始,与所有实验室,尤其是与RHC执行水平较高的10个实验室,持续举行教育会议。由于这种持续干预,医疗保险患者中RHC的比率从1992年的89/100,000降至1996年的65/100,000受益人。从另一个角度看,接受RHC的接受导管检查的医疗保险患者的百分比从1992年的30.5%降至1996年的17.4%。10个实验室中的下降更为显著;接受导管检查的医疗保险患者中接受RHC的百分比从1992年的89.1%降至1996年的31.6%。同期医疗补助患者的相应下降幅度从92.8降至32.7%。该研究结果表明,许多之前在冠状动脉疾病患者中进行的RHC是常规操作,并无医学指征。本研究记录的4年期间RHC的显著下降证明了医疗服务提供者和同行评审组织共同开展的质量改进努力的成功。